Stride, Inc. LRN gained 17.9% since it released its second-quarter fiscal 2025 results on Jan. 28, 2025. The stock’s strong ...
Incyte Corporation INCY reported fourth-quarter 2024 adjusted earnings of $1.43 per share, which missed the Zacks Consensus ...
Despite AVTR's stability in proprietary chemicals and specialty procurement sales, it reports an overall soft fourth-quarter ...
GNRC's fourth-quarter performance is likely to have gained from strength in the home standby generators category. Weakness in ...
Equities research analysts at Zacks Research lowered their Q3 2025 EPS estimates for Choice Hotels International in a report ...
ET's fourth-quarter earnings are likely to have benefited from its fee-based contracts and contributions from its assets spread across major production basins.
REG's Q4 results reflect higher same property net operating income and base rents amid healthy leasing activity.
Strength in the Server & Storage System segment is likely to have aided SMCI's top and bottom-line growth in the second ...
Investment analysts at Zacks Research raised their Q3 2025 earnings per share estimates for shares of Atlassian in a research ...
The headline numbers for Prestige Consumer Healthcare (PBH) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics ...
Over the past month, shares of this world's largest chipmaker have returned -2.5%, compared to the Zacks S&P 500 composite's +1% change. During this period, the Zacks Semiconductor - General industry, ...
Xylem (XYL) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $0.99 per share a year ago. These figures are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results